Skip to main content

Table 3 Changes in ART regimen anchor drug between enrolment and 48 weeks

From: Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis

Anchor drug at enrolment

Anchor drug at 48 weeks

NNRTIs

PIs

INSTI

Total

NVP

EFV

LPV

ATV

  

NNRTIs

NVP

122

6

3

1

0

132

EFV

1

115

3

7

0

126

PIs

LPV

0

1

28

1

0

30

ATV

0

0

0

56

0

56

INSTI

 

0

0

0

0

2

2

Total

 

123

122

34

65

2

346